But 15% weight loss is still clinically significant, and for many people, semaglutide delivers excellent results with potentially better tolerability
Acute Kidney Injury : Due to the potential for volume depletion from gastrointestinal side effects, kidney function should be monitored in patients with renal impairment
The studied GLP-1 RAs included exenatide [14, 35, 37, 39], liraglutide [27, 36,37,38,39], semaglutide [27, 34, 37,38,39], lixisenatide [37, 39], dulaglutide [37, 39], albiglutide [39] and the dual agonist (GLP-1 and Glucose-dependent insulinotropic polypeptide (GIP)) tirzepatide [29, 37]
P 40% to 65 years or older, a newly developed ejection fraction 300 to 5000) and were treated with renin-angiotensin system blockade